Satellite Banner
Technology Networks Header
Friday, October 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Thermo Fisher Scientific Launches Pre-calibrated FT-NIR Analyzers for Increased Speed and Efficiency in Food and Agriculture Analyses
Monday, August 22, 2011
Pre-calibrated solutions rapidly analyze multiple components simultaneously without consumables, chemicals or disposable costs, saving users both time and money.

Integromics Announces Winners of Proteomics Grant Competition
Tuesday, June 28, 2011
University College Dublin and USDA-ARS win competition designed to promote proteomics research in life sciences.

Randox Drug Residues Release Newly Improved Multi-Sulphonamide Testing Platform
Friday, June 24, 2011
Multiplex testing platform allows for the simultaneous detection of 15 of the most commonly abused sulphonamides in food production and agricultural industries.

New Ames Tests Now Available from Cambio
Thursday, June 23, 2011
Designed to reduce the amount of test compounds and consumables used, and to require less hands-on time.

Cargill launches Clear Valley® 80 High Oleic Canola Oil
Friday, June 17, 2011
Cargill introduced its newest healthier oil – Clear Valley® 80 High Oleic Canola Oil – a natural, high oleic oil that delivers the same nutritional benefits featured in earlier generations of Clear Valley products. It has low levels of saturated fat, zero grams trans fat (per 14 gram serving), and a cost-saving solution due to its exceptional shelf life.

Pesticide Analyzer Reference Package Simplifies POPs Analysis
Thursday, June 02, 2011
Thermo Fisher Scientific Inc. announces the second version of the Pesticide Analyzer Method Reference, a unique reference guide that simplifies the analysis of an expanded number of pesticides in environmental and food samples.

Fast Dynamic Array™ IFC for Ag-Bio & Genotyping Studies
Friday, May 27, 2011
Fluidigm introduces its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour.

GE’s Biogas Engines to Power China’s Largest Ethanol Production Plant
Monday, April 18, 2011
GE’s Jenbacher biogas technology to help China boost ethanol production and generate renewable electricity for regional grid.

ThalesNano Launches Next Generation Version of Best Selling Flow Reactor: The H-Cube Pro™
Monday, April 04, 2011
Offers greater hydrogen production for higher throughput, wider temperature capability and an all new graphical interface with real time reaction monitoring/data logging.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 99
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv